Anti-fap/interleukin-2 Fusion Protein Ro6874281 Uses, Dosage, Side Effects and more
Anti-fap/interleukin-2 Fusion Protein Ro6874281 is under investigation in clinical trial NCT03193190 (A Study of Multiple Immunotherapy-based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-pancreatic Cancer)).
| Trade Name | Anti-fap/interleukin-2 Fusion Protein Ro6874281 |
| Generic | RO6874281 |
| RO6874281 Other Names | Anti-fap/interleukin-2 fusion protein ro6874281, Simlukafusp alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
